GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp - Ordinary Shares - Class A

WGS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.57B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
GeneDx Holdings Corp - Ordinary Shares - Class AGeneDx Holdings Corp - Ordinary Shares - Class A-13.9--45%3.50.9
$86.00

Target Price by Analysts

64.2% upsideGeneDx Holdings Target Price DetailsTarget Price
$-140.29

Current Fair Value

367.9% downside

Overvalued by 367.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.57 Billion
Enterprise Value$1.69 Billion
Earnings per Share$-0.73
Beta1.99
Outstanding Shares29,880,144

Return

Return on Equity-45.38%ROE
Return on Assets-21.09%
Return on Invested Capital-15.61%

Valuation & Multiples

P/E Ratio-13.85P/E Ratio
PEG-22.54PEG
Price to Sales3.49Price to Sales
Price to Book Ratio6.55Price to Book Ratio
Enterprise Value to Revenue3.67
Enterprise Value to EBIT-23.77
Enterprise Value to Net Income-16
Total Debt to Enterprise0.13
Debt to Equity0.88Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 9, 2026
EPS
$0.28
Est. $0.07
Revenue
$123.10 M
Est. $122.93 M

Next Earnings Call

Expected Date
February 22, 2027
EPS Estimate
$0.31
Consensus analyst estimate
Revenue Estimate
$136.07 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 35.41%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %19.45%▼ 88.81%
Total Invested$417.71M▼ 80.84%
Investors Holding74▼ 168.00%

About GeneDx Holdings Corp

3 employees

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and g...

GeneDx Holdings Insider Information FAQ

Stockcircle tracks 6 top investors with a current 13F position in GeneDx Holdings. Notable holders include ARK Invest. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 6 open-market insider purchases and 9 open-market insider sales for GeneDx Holdings in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.